Ruston M. Koonce
Role not yet determined Is this you? Add your title
Formerly Arkansas Affiliated with UAMS through 2023.
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Ruston M. Koonce's research focuses on the analysis of health outcomes related to substance use disorders and chronic conditions. His work has investigated the association between opioid therapy trajectories and adverse health events, as well as the relationship between suspected long-COVID and stimulant prescribing patterns in the United States. Koonce has also explored the development of models for identifying alcohol use disorder using electronic health record data, with a focus on clinical implementation and the potential impact of neighborhood-level social determinants of health. Additionally, his research has examined cardiovascular outcomes in patients with type 2 diabetes initiating specific medications. Koonce's collaborators include Bradley C. Martin and Laura E. Gressler from the University of Arkansas for Medical Sciences.
Metrics
- h-index: 2
- Publications: 3
- Citations: 11
Selected Publications
-
The association between suspected long–COVID and stimulant prescribing in the United States (2023)
-
CO57 Cardiovascular Outcomes in Patients with Type 2 Diabetes and Atherosclerotic Cardiovascular Disease Initiating SGLT2 or GLP-1 Medications within Federated-Real-World Data (2022)
-
Association between opioid therapy trajectories and potential opioid‐related adverse health events (2022)
Collaboration Network
Top Collaborators
- Association between opioid therapy trajectories and potential opioid‐related adverse health events
- CO57 Cardiovascular Outcomes in Patients with Type 2 Diabetes and Atherosclerotic Cardiovascular Disease Initiating SGLT2 or GLP-1 Medications within Federated-Real-World Data
- Association between opioid therapy trajectories and potential opioid‐related adverse health events
- The association between suspected long–COVID and stimulant prescribing in the United States
- Association between opioid therapy trajectories and potential opioid‐related adverse health events
- Association between opioid therapy trajectories and potential opioid‐related adverse health events
- Association between opioid therapy trajectories and potential opioid‐related adverse health events
- CO57 Cardiovascular Outcomes in Patients with Type 2 Diabetes and Atherosclerotic Cardiovascular Disease Initiating SGLT2 or GLP-1 Medications within Federated-Real-World Data
Similar Researchers
Based on overlapping research topics